A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma
| Publication | Article in British Journal of Haematology, published June 2017 |
|---|---|
| Authors | Guy Pratt, Christina Yap, Ceri Oldreive, Daniel Slade, Rebecca Bishop, Mike Griffiths, Martin J....[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…